Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.27+0.12 (+1.47%)
Close on Nov 18, 2026Market cap $288.48MP/E –Yield –
Benitec Biopharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Benitec Biopharma's pe ratio was 179.1× on Jul 31, 2020.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Jul 31, 2020 | 179.1× | −12.8 |
| 2019 | Dec 31, 2019 | 191.9× | – |
See a number that looks wrong?